Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Accounts Payables (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Accounts Payables for 16 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 38.12% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, down 38.12% year-over-year, with the annual reading at $3.2 million for FY2025, 38.12% down from the prior year.
  • Accounts Payables hit $3.2 million in Q4 2025 for Ligand Pharmaceuticals, down from $3.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $19.2 million in Q2 2022 to a low of $1.8 million in Q2 2024.
  • Historically, Accounts Payables has averaged $7.2 million across 5 years, with a median of $5.8 million in 2023.
  • Biggest five-year swings in Accounts Payables: tumbled 84.42% in 2023 and later skyrocketed 378.75% in 2025.
  • Year by year, Accounts Payables stood at $8.4 million in 2021, then crashed by 36.84% to $5.3 million in 2022, then tumbled by 54.27% to $2.4 million in 2023, then skyrocketed by 115.62% to $5.2 million in 2024, then plummeted by 38.12% to $3.2 million in 2025.
  • Business Quant data shows Accounts Payables for LGNDZ at $3.2 million in Q4 2025, $3.7 million in Q3 2025, and $8.6 million in Q2 2025.